SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001561743-17-000015
Filing Date
2017-05-03
Accepted
2017-05-03 16:07:37
Documents
45
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q kindred10qq12017.htm 10-Q 528700
2 EXHIBIT 31.1 exhibit311q12017.htm EX-31.1 13283
3 EXHIBIT 32.2 exhibit321q12017.htm EX-32.2 6849
  Complete submission text file 0001561743-17-000015.txt   3415825

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT kin-20170331.xml EX-101.INS 752076
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kin-20170331.xsd EX-101.SCH 26072
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT kin-20170331_cal.xml EX-101.CAL 45401
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT kin-20170331_def.xml EX-101.DEF 132445
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kin-20170331_lab.xml EX-101.LAB 363030
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kin-20170331_pre.xml EX-101.PRE 209890
Mailing Address 1555 BAYSHORE HIGHWAY, SUITE 200 BURLINGAME CA 94010
Business Address 1555 BAYSHORE HIGHWAY, SUITE 200 BURLINGAME CA 94010 650-701-7901
Kindred Biosciences, Inc. (Filer) CIK: 0001561743 (see all company filings)

IRS No.: 461160142 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36225 | Film No.: 17809186
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1